Catalent (CTLT) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

PharmaConsumerHealthBiologics
0250M500M750M1B1B2B2B2BQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Revenue by Geography

North AmericaEuropeInternational Other
0250M500M750M1B1B2B2B2BQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
0375M750M1B2B2B2B3B3BQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
0815223038455260Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Operating Expenses

Research And Development ExpensesSelling General And Administrative ExpensesOther Expenses
038M75M112M150M188M225M262M300MQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025

EBITDA

EBITDA
-800M-650M-500M-350M-200M-50M100M250M400MQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025

EPS

EPSEPS Diluted
000001111Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Revenue Variation (%)

Revenue Variation
-30-22-15-808152230Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
02505007501K1K2K2K2KQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-20-14-8-1511182430Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
01020304050607080Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Price-to-Earning Ratio

P/E Ratio
-30-1285685114142171200Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Income Breakdown

Operating IncomeTotal Other Income Expenses NetNet Income
038M75M112M150M188M225M262M300MQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
0124568910Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
062M125M188M250M312M375M438M500MQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Free Cash Flow

Cash At End Of Period
050M100M150M200M250M300M350M400MQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
038M75M112M150M188M225M262M300MQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025
🏦 Balance Sheet
📈 Key Metrics